chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small dime-sized bump at injection site next day (January 27, 2021) after injection has grown to 2" diameter ten days later, Friday, February 5, 2021.  Severe itching at injection site for approximately four days.
Developed a rash that spread over my torso, from neck to upper thighs. It was red and itchy. Sought treatment from a dermatologist approximately 10 days after the rash started as over-the-counter treatments were not helping. The dermatologist determined it was pityriasis rosea and prescribed Triamcinolone Acetonide cream.  I applied the cream topically for 14 days and the rash started to diminish. There are a few dark patches still clearing up but it no longer itches.
Within 48 hours I developed fever with chills. I became very weak and lethargic. Severe migraine and body aches and nausea. The above symptoms lasted over 2 weeks and I?m still not well. The very thing the vaccine was supposedly supposed to prevent caused severe illness. I had already had covid several months prior but was forced into getting this vaccine or lose my livelihood and when having actual covid I had no symptoms but the vaccine caused me to become severely ill!!! Now I have to go through this all over with the second shot!
Around 5:30 PM on 10/1/2013 pt noticed itchiness, redness, and soreness near site of injection. Appears to be a small outbreak of chicken pox around site.
Had inner gluteal pain starting four days after vaccination and lasting for four days. Pain relieved with anti-inflammatories.  No other symptoms. Declined follow-up with his PCP.
At approximately 1030, patient received second dose of Moderna vaccine. At approximately 1035, patient reported to RN that she developed itchiness on the back of her neck/upper back. Doctor and RN, pulled patient into privacy and inspected the neck, upper back, and shoulders, noticing a red patchy rash. Patient had been scratching the area. Denied angioedema, respiratory distress, swelling of head/neck, trouble swallowing, or spread of rash. Consulted with medical director, via phone. Advised to give Benadryl 50mg and monitor 30 minutes. Patient took Benadryl 50mg. Initial blood pressure 115/82. Patient states her normal blood pressure is 80/50 as she is a long distance runner. Blood pressure taken again before patient left, at 93/59. Patient was talking and laughing with colleague and vaccinators with no complaints, and left after 30 minutes with no further complications.
There was no adverse event. This report is to report a medication error. This RN inadvertently administered an adult dose to a eleven year old child.
Rash developed on arm about a week after receiving the first dose.  It spread over 1/3 of my upper arm.  Was very tender , red, warm to the touch, and had a slight itch.  I took benadryl and tylenol for the pain and discomfort.  It is now three week after my initial shot and the rash has almost gone away.  I can still see some lingering redness but nothing like what I originally had and it is still a little tender to the touch/
A spontaneous report was received from a consumer (United States) concerning a 21-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fell out of the chair and passed out/Loss of consciousness, fell out of the chair and passed out/Fall, may have been a seizure but unsure/seizure.    The patient's medical history included psychological problems. Concomitant product use was not provided by the reporter.    On an unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number unknown) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, after the injection he "fell out of the chair and passed out". The reporter stated that she heard it "may have been a seizure but unsure". She reported the male was obese. The events passed out and seizure was considered as medically significant. Treatment information was not provided.    Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events fell out of the chair and passed out, may have been a seizure but unsure was unknown at the time of this report.; Reporter's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Localized reaction at injection site - redness, heat, swelling, itching, pain 1 day after vaccination.
upset stomach, vomiting 7 or 8 times, diarrhea fever 101.6
pt recvd vax; was screaming; had episode of uncontrollable cry; t of 102; seen at er on 10nov94;
Fever followed by swollen lymph node under left arm (armpit area).  It's about the size of a lemon and very painful/tender.
Mother reported patient was having jerking "ticks" and was taken to pcp in November when symptom started. PCP thinks was due to vaccines. Patient has appt with neuro in Jan 2019.
At 1935 received the first dose of Pfizer at 1935. At 1952, the client's partner approached the EMT table to report the client was complaining of his "heart racing." EMT responded at that time. The client was sitting in his seat in no obvious distress, no swelling observed around his mouth or tongue, skin color appeared normal. At 1955, the client's vital signs were as follows: heart rate 65, respiratory rate 12, O2 96%, and blood pressure 110/palpable (the client continued to move his arms during the blood pressure reading.) Per the client, he did eat breakfast that day, but no dinner, and he just drank some coffee. The client stated that he has no medical history, takes no medications, and has no allergies. At 2001, the client's heart rate was 70 and his O2 was 97%. The client stated that his symptoms had resolved at this time and refused Benadryl. The client stated that he wanted to go home and his partner stated she would drive him. Education provided regarding recommended 30 minute observation, AMR activation and emergency management,, and primary care follow up. The client left the building at 2005 accompanied by his partner, ambulating with a steady gait.
Little more fatigued after second dose; 5-7 days after second dose atopic dermatitis was starting to go away/ after 10- 14 days the atopic dermatitis cleared up/ Now there is only a little tiny little bit left; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Little more fatigued after second dose) and DERMATITIS ATOPIC (5-7 days after second dose atopic dermatitis was starting to go away/ after 10- 14 days the atopic dermatitis cleared up/ Now there is only a little tiny little bit left) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     Concurrent medical conditions included Atopic dermatitis, Eczema and Psoriasis (mainly on the palms of their hands, on the inside of their elbows, on the back of knee,  in the lower back and in the inguinal area, and inner thigh.).    On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced DERMATITIS ATOPIC (5-7 days after second dose atopic dermatitis was starting to go away/ after 10- 14 days the atopic dermatitis cleared up/ Now there is only a little tiny little bit left). On an unknown date, the patient experienced FATIGUE (Little more fatigued after second dose). At the time of the report, FATIGUE (Little more fatigued after second dose) and DERMATITIS ATOPIC (5-7 days after second dose atopic dermatitis was starting to go away/ after 10- 14 days the atopic dermatitis cleared up/ Now there is only a little tiny little bit left) outcome was unknown.            The treatment history was not reported. The concomitant medication was not reported.  The patient stated that after 5 to 7 days of receiving the second dose, there was an evidence that  atopic dermatitis started to go away, and after about 10 to 14 days, his atopic dermatitis cleared up.   Patient also stated that have not been cured of the atopic dermatitis.   This case was linked to MOD-2021-297399 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Follow up received on 30-AUG-2021, report contains patient demographics , facility information where vaccine given and outcom of event information were added.
Employee reports that her left arm, shoulder and neck up to her ear became very swollen and red with a blotchy rash.  Arm is still somewhat sore, but swelling and redness are gone.
chills; body aches; 102.3 degree fever; headache; This is a spontaneous report from a contactable other healthcare professional. A 27-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 15Feb2021 11:00 (Batch/Lot Number: EN6201) (at the age of 27-years-old) as DOSE 2, SINGLE for covid-19 immunization. Medical history included generalised anxiety disorder. There were no known allergies reported. Concomitant medications included dicyclomine, fish oil, iron and acetylcysteine (NAC 500). All taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 21Jan2021 10:00 (Batch/Lot Number: EL8982) for covid-19 immunization. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine. The patient did not have covid prior to vaccination and was not tested for covid since vaccination. On 16Feb2021 12:30, the patient experienced headache, chills, body aches and 102.3 degree fever. It was reported that exactly 13 and a half hours after receiving second vaccine, the patient developed sever chills and at about 15 hours she developed significant body aches and a 102.3 degree fever. The fever continued for the remainder of the day and fell below 100 only twice. 48 hours after the second vaccine the ppatient still have a severe headache. However, the body aches and headache seem to have subsided. Laboratory tests included body temperature: 102.3 degree. The clinical outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
9am Sat 7/22/06 well child visit and given Immunizations listed below, mom noted redness around Hep B site prior to leaving office and stated still red that PM in ER. Did not not rash all over until 7PM that same evening. Child started vomiting and became listless, parents called 911 and ambulance transported to medical center for evaluation.
He had the nasal and the cough; He had the nasal and the cough; Aching all over; This is a spontaneous report from a contactable consumer (Patient's father). A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration on an unspecified date in 2021 as dose 2, single for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. On an unspecified date in 2021, the patient had the nasal and the cough, and aching all over. The reporting father stated that his son got it and his second one really hit him hard. He missed a days work and he never misses a day work and his second shot bothered him and his first shot did not. He did not run a temperature, but he had the nasal and the cough and the aching all over and he was still dealing with it (on 2021) and he had his second shot Monday or Friday but he was getting better. The outcome for the events was recovering.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.
Information has been received from a registered nurse concerning a 12-year-old white female with no pertinent medical history or allergies who on 18-MAR-1999 was vaccinated in her right deltoid with her first dose of Varivax (Lot # "1658A"). There were no illnesses at the time of vaccination. There was no concomitant medication. On 06-SEP-2007 the patient developed red, itchy bumps on her abdomen, flank, back, chest, and neck. She also experienced upset stomach, lethargy, sore throat and headache. No diagnostic labs were performed. The patient was treated with FAMVIR 250 mg, 2 tablets, twice a day, for seven days. on 13-SEP-2007 the patient recovered from the adverse events. The events were considered to be an other important medical event by the reporter. This is one of several reports received from the same source. No further information is expected.
CHILLS, TEMP, BODY ACHES, NAUSEA & VOMITING. INCREASED BODY PAIN. R ARM PAIN, REDNESS, SWELLING. HEADACHE, DIZZY. SEVERE BACK PAIN. STINGING AND HOT. BRIGHT RED RASH R ARM. PER DR.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender. Medical history and concurrent conditions were not provided. On 29-MAY-2014, the patient was inadvertently vaccinate4d with an improperly stored dose of GARDASIL lot # K009482 expiry date: 06-MAR-2017 (dose and route were not reported). No adverse effects reported or Product Quality Complaints (PQC) involved. There was no concomitant medication provided. This is one of several reports received from the same reporter. Additional information is not expected because the reporter refused additional contact.
Full body hives and severe headache- no breathing issues-pt took Benadryl and slept all night-woke up this AM and no hives were present. Minimal headache.
Fullbody aches and fatigue - ongoing Migraine - ongoing Nausea - ongoing
Child was given vaccination-started crying and cried non-stop for 8 1/2 hrs. Motrin and warm bath helped.
Pt vaccinated with HIB experienced "Vaccine failure" (disease onset 24 hrs after vaccination). Identified in a surveillance study.
Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of ZOSTAVAX vaccine (Oka/Merck). The patient got shingles after getting vaccinated with ZOSTAVAX vaccine (Oka/Merck). The outcome was unknown. It was unknown if the patient sought medical attention or not. The pharmacist had no other information. No further information is available.
This spontaneous report as received from a nurse practitioner refers to an 81 years old female patient. The patient's medical history included drug reactions/allergies to penicillin, sulfa, cephalosporins and tramadol hydrochloride. The patient also had a lymphoma 4 years ago, for which she was not currently receiving any treatment or medication. On 08-OCT-2012 the patient was vaccinated with ZOSTAVAX (vial 19400). Information regarding dose, dose number, route and lot number was not provided. No other co-suspects were reported. Concomitant medications included: ZOMETA. Two weeks after receiving ZOSTAVAX (approximately 22-OCT-2012) the patient experienced shingles. The patient had sought medical attention (office visit). No relevant tests were performed. The patient received VALTREX as treatment for the event. On 07-NOV-2012 the patient recovered from the event. A reporter causality for shingles was not provided for ZOSTAVAX. Additional information has been requested.
This case is considered medically important (OMIC). Information regarding a polio vaccine was received from an attorney regarding a female patient who received a dose in the late 1950's early 1960's. The patient has a past history of chemical poisoning. She was reportedly exposed to asbestos and asbestos-containing products. Indication for the polio vaccine was immunization. Product was administered on an unspecified date in the late 1950's early 1960's. Concomitant medications were not reported. According to the legal complaint, the plaintiff was diagnosed with mesothelioma on or about 1/03. Reportedly, the plaintiff received a polio vaccination that was contaminated with SV40 virus which was a substantial factor, and therefore a cause of the plaintiff's mesothelioma. The legal complaint states that the plaintiff's exposure to asbestos, asbestos-containing products, talc and talc-containing products and the SV40 virus caused severe and permanent injury to the plaintiff including, but not limited to breathing difficulties, asbestosis, lung and/or other cancer, mesothelioma, and/or other lung damage. On or about 1/03, the patient was diagnosed with mesothelioma.
Febrile Seizures on 11/06/2002.  Temp. 102.5 and URI with otitis media but occured 8 days after MMR Varivax. Describes as infrequent jerky spasms of arms and legs (few seconds between) lasted maybe 15 min.
Developed a mullbilliform rash; This is a spontaneous report from a contactable physician. This report was received via a sales representative. A 14-year-old patient of an unknown gender received second dose of BNT162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Previously, the patient received the first dose of BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization and no reaction on previous exposure to drug was reported. On an unknown date, the patient developed a mullbilliform rash after the 2nd dose of the Pfizer COVID-19 vaccine. The outcome of the event was unknown.  Follow-up attempts are needed. Information on Lot/Batch number can be obtained.
Body aches, joint pains, fever, severe chills, muscle spasms, and fatigue began 12 hours post vaccination. Fever and chills lasted approximately 17 hours. Fatigue, body aches, joint pains last 4 days. Severe left TMJ pain began 31 hours post vaccination. Debilitating pain and muscle spasms continued. Chiropractor adjustment day 7. Family doctor consulted day 11 and started steroid and muscle relaxer. Dentist consulted day 14 and referred to physical therapist, recommended massage therapy and continued chiropractor care. Referral to oral surgeon if no improvement in 1 week.
Vaccine was administered 2 days after the Beyond-Use-Date of 6/9/2022
Vaccination given on Jan 9, 2021 with only effect a sore arm for one day.  On Jan 18, 2021, developed a circular rash, approx 3? long and1 and 1/2? wide in vicinity of the vaccination.  Rosy colored, warm with a hard spot in the middle.  Painful at first, then itchy.  Rash began fading slightly next day, Jan 19, and became itchy but not painful.  Lasted several days, continuing to fade and become less itchy.   By Jan 23, just very mild pink discoloration and very mildly sensitive to the touch.  Then disappeared all together.  The entire episode resembled something like a bee bite.
Sore arm, pink circle w/ tiny white center at injection site. Soreness in arm got worse and evening progressed. Interfered with sleep. Did not take medication . Next day, 10/28/2021, no appetite, achy and stiff, tired, sleep off and on all day. Injections site reactions was bigger yet fainter, 1 1/2 to 2 inches around. Less painful, no trouble sleeping. 10/29/2021, sore arm and arm pit. Still tired, possible chills. Small pink circle with red center at injections site. On inside of arm, 2inch above and 3 to 4 inches below injection site, there was blotchy light pink rash. No itch with rash. Slightly feverish overnight. 10/30/2021, rash was darker pink and achy. Slight chills. Temperature 1 degree higher than  normal. Overnight, slightly feverish, slept well. 10/31/2021, briefly feverish No longer had underarm tenderness. Sore arm was gone. Covid rash was barely visible. 11/01/2021 all symptoms resolved.
Vaccine not working(Lack of efficacy); This spontaneous case was reported by a consumer and describes the occurrence of DRUG INEFFECTIVE (Vaccine not working(Lack of efficacy)) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DRUG INEFFECTIVE (Vaccine not working(Lack of efficacy)). At the time of the report, DRUG INEFFECTIVE (Vaccine not working(Lack of efficacy)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided by the reporter. Company comment: This is a spontaneous case concerning a 65-year-old female patient with a current history of multiple sclerosis, under OCRELIZUMAB as a treatment, who experienced the unexpected event of drug ineffective, reported as Vaccine not working (Lack of efficacy). It is unknow the number of doses received by this patient, also vaccination date and when the event lack of efficacy occurred. Concomitant medication of OCRELIZUMAB, could be a confounder. This case does not meet criteria for lack of efficacy; however, no further information was reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 07-Dec-2021: Follow up updated reporter type to consumer also concomitant medication added.; Sender's Comments: This is a spontaneous case concerning a 65-year-old female patient with a current history of multiple sclerosis, under OCRELIZUMAB as a treatment, who experienced the unexpected event of drug ineffective, reported as Vaccine not working (Lack of efficacy). It is unknow the number of doses received by this patient, also vaccination date and when the event lack of efficacy occurred. Concomitant medication of OCRELIZUMAB, could be a confounder. This case does not meet criteria for lack of efficacy; however, no further information was reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Developed shingles on arm where administered.  Symptoms for shingles developed within 2 days after receiving the Hepatitis B vaccine.  Started with numbness and tingling.  Rash started on 10/9/02. Started on Veltrex on 10/9/02 for 7 days.
Severe headache 10 pm Fever and chills 1 am Blood sugar spikes about 350 1 am
Child recieved second dose of Varicella vaccine on June 30, 2008. Mother called on 7/16/2008 and left message stating child had Doctor documented case of Chicken Pox. Child woke up on 7/12/2008 with "a nickel size red spot on stomach and then the next day blisters appeared.  On 7/14/2008 more blisters appeared around the larger one on the abdomen".Today when I called and talked to the mother she said there were two smaller "pox" on the child's back.
Injection device malfunction. Needle dis-assembled from syringe base as patient was being injected. Less than half the dose was administered. Dose was immediately repeated. Patient is doing well
I took a third Moderna vaccine 8 months after my second Moderna vaccine.  1 week later, I began getting itchy crops of bumps, which I mistook for bug bites. This progressed to extensive urticaria, dermatographia, and even very mild angioedema of my throat. It improved significantly with claritin.  I finally realized this is probably due to Moderna vaccine since this began 1 week after the vaccine, and I've never had these problems before.  It is now 2 weeks after my Moderna vaccine, and I am still having urticaria, worse with pressure.